Associations between cadmium exposure and circulating levels of sex hormones in postmenopausal women
Autor: | Marie Vahter, Göran Samsioe, Jonas Lidfeldt, Thomas Lundh, Annette Engström, Agneta Åkesson, Staffan Skerfving, Krister Halldin, Imran Ali |
---|---|
Rok vydání: | 2014 |
Předmět: |
medicine.medical_specialty
Urinary system medicine.medical_treatment Biochemistry chemistry.chemical_compound Breast cancer Sex hormone-binding globulin Internal medicine medicine Humans Androstenedione Gonadal Steroid Hormones Testosterone General Environmental Science Creatinine biology business.industry Hormone replacement therapy (menopause) Middle Aged medicine.disease Postmenopause Endocrinology chemistry biology.protein Female business Cadmium Hormone |
Zdroj: | Environmental Research. 134:265-269 |
ISSN: | 0013-9351 |
DOI: | 10.1016/j.envres.2014.08.009 |
Popis: | Recent epidemiological as well as in vivo and in vitro studies collectively suggest that the metalloestrogen cadmium (Cd) could be a potential risk factor for hormone-related cancers in particularly breast cancer. Assessment of the association between Cd exposure and levels of endogenous sex hormones is of pivotal importance, as increased levels of such have been associated with a higher risk of breast cancer in postmenopausal women. The present study investigated the perceived relationship (multivariable-adjusted linear regression analyses) between Cd exposure [blood Cd (B-Cd) and urinary Cd (U-Cd)], and serum levels of androstenedione, testosterone, estradiol, and sex-hormone binding globulin (SHBG), in 438 postmenopausal Swedish women without hormone replacement therapy (HRT). A significant positive association between B-Cd (median 3.4 nmol/L) and serum testosterone levels, as well as a significant inverse association between B-Cd and serum estradiol levels and with the estradiol/testosterone ratio were encountered. However, U-Cd (median 0.69 nmol/mmol creatinine) was inversely associated with serum estradiol levels only. Our data may suggest that Cd interferes with the levels of testosterone and estradiol in postmenopausal women, which might have implications for breast cancer risk. |
Databáze: | OpenAIRE |
Externí odkaz: |